This study shows that, in human brain, CSF1R colocalizes with microglial markers and is elevated in autopsy tissue from patients with PD compared with individuals in a control group and presents data on the use of [11C]CPPC to measure CSF1R binding in early stage PD patients. This evidence concerns the gene CSF1R and Parkinson disease.